STAT+: Pharmalittle: Moderna must face patent claims over its Covid-19 vaccine; Pfizer and BioNTech testing combo Covid and flu shot
STAT News
NOVEMBER 3, 2022
The companies allege Moderna’s vaccine uses their technology for a drug-delivery system without permission. Citing The single-dose vaccine candidate is a combination of Pfizer’s mRNA-based flu shot and the Omicron-tailored Covid-19 booster shot developed by both companies.
97 
Let's personalize your content